#glp-1

• The GLP-1 Adherence Crisis
  2026-03-19

  Most GLP-1 patients stop within a year. Here's why adherence — not efficacy — is the defining challenge in metabolic therapy.

  Tags: glp-1, metabolic health, adherence, health policy
• The Real GLP-1 Problem Isn’t Starting — It’s Staying On
  2026-03-19

  A new BMJ Medicine study suggests stopping GLP-1 drugs may quickly erase their cardiovascular benefits.

  Tags: opinion, analysis, metabolic health, glp-1